Skip Navigation

European Heart Journal 1999 20(17):1261-1270; doi:10.1053/euhj.1998.1307
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Maier, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maier, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Audit and quality control in angioplasty in Europe: procedural results of the AQUA Study 1997; assessment of 250 randomly selected coronary interventions performed in 25 centres of five European Countries

W. Maierf1, M.F. Enderlin, T. Bonzel, N. Danchin, G. Heyndrickx, V. Mühlberger, K.L. Neuhaus, F. Piscione, N. Reifart, J. Antoni, Y. Ogurol, M.B. Wischnewsky and B. Meier on behalf of the AQUA Study Group, Nucleus Clinical Issues, Working Group Coronary Circulation, of the European Society of Cardiology

Department of Cardioloy, University Hospital, Bern, Switzerland
Centre for Computing Technology, University of Bremen, Germany

revised September 14, 1998; accepted September 23, 1998

Abstract

Aims Percutaneous transluminal coronary angioplasty (PTCA) has become the most widely used major intervention in western medicine. However, there is disparate use of this technique among different European countries and the U.S.A. In an attempt at quality assurance, the working group Coronary Circulation of the European Society of Cardiology has carried out a study on appropriateness, necessity, and performance of PTCA in Europe. The present paper reports on the procedural results of this survey.

Methods In a multicentre case-control study in Europe, 750 patients (544 men, 206 women) with documented vascular disease of the From the countries participating in the European Registry of Coronary Intervention, the three countries with the highest absolute PTCA volume (Germany, France, and the United Kingdom) and two randomly selected countries (Belgium and Italy) were chosen for investigation. In these countries, five centres were selected at random according to the following criteria: one centre with >1000, three centres with 300–1000, and one centre with <300 procedures per year. In each of these, 10 cases from the first half of 1997 were randomly identified and all pertinent documentation was collected.

Results In 250 cases, 325 stenoses were addressed as target lesions. Single vessel disease was present in 41%. History included stable angina in 49%, unstable angina in 32%, atypical chest pain in 6%, no anginal pain in 12%, and acute/subacute myocardial infarction in 13%. The percentage of patients with either positive stress test and/or unstable angina, acute/subacute infarction, previous infarction (within 6 months) or coronary revascularization amounted to 98%. Single vessel intervention accounted for 90%. In 41% balloon-only angioplasty was performed and in 54% at least one stent was implanted with considerable variation among countries. The use of other new devices amounted to only 3%. In 92%, the operators documented a successful procedure. Major complications (myocardial infarction, emergency bypass surgery, or death) were found in 4·8%.

Conclusions Based on scrutinized hospital and operator data, the present study revealed a satisfactorily high percentage of justifiable indications, an adequate procedural success rate, and an acceptably low complication rate. Further analysis by an expert panel will address appropriateness, necessity, and procedural performance of the individual cases.

Key Words: Audit, coronary angioplastymultinational European study, procedural results, PTCA, quality control

f1 Correspondence: Bernhard Meier, MD, Professor and Head of Cardiology, Inselspital, University Hospital, 3010 Bern, Switzerland.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
W. Maier, O. Mini, J. Antoni, M. B. Wischnewsky, and B. Meier
ABC Stenosis Morphology Classification and Outcome of Coronary Angioplasty : Reassessment With Computing Techniques
Circulation, March 6, 2001; 103(9): 1225 - 1231.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. W. Serruys, B. de Bruyne, S. Carlier, J. E. Sousa, J. Piek, T. Muramatsu, C. Vrints, P. Probst, R. Seabra-Gomes, I. Simpson, et al.
Randomized Comparison of Primary Stenting and Provisional Balloon Angioplasty Guided by Flow Velocity Measurement
Circulation, December 12, 2000; 102(24): 2930 - 2937.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
B. MEIER
Coronary angioplasty is like going to the dentist
Heart, May 1, 2000; 83(5): 491 - 492.
[Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.